Kriya Therapeutics Raises $270M in Series C Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Transhuman Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Transhuman Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Transhuman Capital Today - Breaking & Trending Today
Durham's Kriya Adds $270M to Coffers, Bringing Total Raised to Date to $450.5M for Gene Therapies
Durham's Kriya Therapeutics just added $270 million to its coffers, bringing its total raised to date to roughly $450 million for novel gene therapies
Source: ncbiotech.org
Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran
New York-based Terran Biosciences inked a deal with Paris-based Sanofi for two late-stage central nervous system (CNS) assets. Terran plans to advance them for neurological and psychological indications.
Source: biospace.com
After $100M round, RTP startup Kryia Therapeutics spins out new group focusing on eye diseases
Editor's note: This story is another in the "Startup Spotlight" series which brings into greater view emerging and new technologies. This post is from the N.C.
Source: wraltechwire.com
RTP's Kriya Therapeutics Spins Out New Division Focused on Ocular Diseases | North Carolina Biotechnology Center
Kriya Therapeutics is launching a new division, Kriya Ophthalmology, focused on developing gene therapies for rare and prevalent ocular diseases.
Source: ncbiotech.org